about
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydratesAdvances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumChallenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies.Effect of an environmental school-based obesity prevention program on changes in body fat and body weight: a randomized trial.Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.Blood pressure and stroke risk among diabetic patientsAn environmental intervention to prevent excess weight gain in African-American students: a pilot study.Association of dietary restraint and disinhibition with eating behavior, body mass, and hunger.Why patients seek bariatric surgery: does insurance coverage matter?Efficacy of a pilot Internet-based weight management program (H.E.A.L.T.H.) and longitudinal physical fitness data in Army Reserve soldiers.Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation.Pharmacologic treatment options for obesity: what is old is new again.2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.Body mass index and the risk of dementia among Louisiana low income diabetic patients.Management of obesity.Trunk versus extremity adiposity and cardiometabolic risk factors in white and African American adults.Predicting successful long-term weight loss from short-term weight-loss outcomes: new insights from a dynamic energy balance model (the POUNDS Lost study)Effect of capsinoids on energy metabolism in human subjectsFour-year weight losses in the Look AHEAD study: factors associated with long-term success.Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended releaseBaton Rouge Healthy Eating and Lifestyle Program (BR-HELP): A Pilot Health Promotion Program.Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension studyEffect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study.Abdominal adiposity depots are correlates of adverse cardiometabolic risk factors in Caucasian and African-American adults.Predictors for selection of insurance-funded weight loss approaches in individuals with severe obesity.Medical management of obesity in women: office-based approaches to weight management.BMI guidelines for bariatric surgery in diabetes: how low can we go?GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study.Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.Ethnic differences in self-reported and measured obesity.Weight loss maintenance following a primary care intervention for low-income minority women.Ethnic-specific BMI and waist circumference thresholds.The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differencesConsistency of fat mass--fat-free mass relationship across ethnicity and sex groups.Perceptions community residents have about partner institutions and clinical research.People United to Sustain Health (PUSH): a community-based participatory research study.Medical therapy for the patient with obesity.
P50
Q24652265-05E3038E-5E42-4319-A000-3612A9F5173AQ26784022-0E61DC89-1F48-44DE-9C2A-177D9456D3CEQ27331844-4FD8048C-0ADD-4A2E-80B8-F90D1FFFD841Q30515972-A0FFFD5C-73CC-47D8-B828-3E427DA62FC3Q30548796-46212879-33A5-4CC6-A7CB-2DB53B8E9F11Q33570022-B5587DEA-9D81-4C84-8B07-FF0D0E2325C5Q33854539-1E9D4E7E-5A8F-497F-9BB1-9EA2C60BAA3BQ33936560-45EB5B73-A9A7-4C24-8A9E-378435DF7ED5Q33954064-6991BE8C-5BE5-4C42-BE85-4178E7D4FAC0Q34057739-784FF925-398D-4A50-918C-42F0A952D974Q34073450-4E608C0F-946C-4616-BEE1-E5252BF9900BQ34207023-8DC50FCF-8591-4F5C-B192-CEA30BD7DC82Q34217920-52AE568A-DFD2-4DC6-983B-5CAD12F7D162Q34341681-1A474D89-B894-47BA-9548-A1E5B9B839ECQ34384547-D2E11345-580A-4E07-8530-F2159036772DQ34408201-0D0D0C7E-D0F8-41BE-9392-CF401C19B90DQ34513665-2588561E-3291-4D19-8BC0-7EA029C7893CQ35043335-644A7BEF-5D25-4ECF-BEC3-7CF3A8B586B7Q35120232-11788CA2-29AE-4083-B8D4-4C48BFA1495DQ35190959-4839BC06-0D4E-4646-8CA8-849D503BA5D7Q35242207-20157836-47BD-4D46-8BDF-38B98927BBB2Q35360398-5DA84110-2D39-41D9-A6F5-C949014480B4Q35569652-6CC22AEC-E649-41AC-B8EB-673C829C9FDEQ35677262-589E4291-C0BE-4530-A43B-1377983B11A1Q35788574-6FD8DE6B-12E2-497E-8341-753FBA01DE0AQ35825626-FDC360A4-036B-4A1C-8F7C-37779F2867F1Q35953641-39F70EC8-5830-47C8-8A05-F1EFD071E2C8Q35982757-5B55D5C2-9AE1-49F2-B35B-78B280701503Q36047314-8281B022-C1D5-4009-B140-B8B610FC99EDQ36406821-7375657E-027C-4C89-97B0-050A3461B6CAQ37139925-F4931F24-2592-40D9-BE65-0A7FC208515EQ37151277-3920BFC7-3564-4937-B07A-714F5B0A9EEEQ37365976-9CEFFF41-CF1F-4CA9-8E64-0BC502AE5AA3Q37365992-1DB24434-E878-43B7-AE20-643B9B20C43DQ37601695-18F5A484-8D85-48FB-9D26-728EB538D527Q37651186-65FE9A97-21B5-4122-AF96-64731EEE0E29Q37651223-9A1AF388-D7F2-42AC-B002-8D1A9F8A5884Q37677086-C79664B8-4592-4E1B-8B7E-51617DB45398Q37735470-A8BAC4D1-3EBE-468F-B33D-34D503159A2AQ37999778-BB77170E-2653-4CBD-BD52-4DE6E31EA028
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Donna H Ryan
@nl
Donna H Ryan
@sl
Donna H. Ryan
@en
Donna H. Ryan
@es
type
label
Donna H Ryan
@nl
Donna H Ryan
@sl
Donna H. Ryan
@en
Donna H. Ryan
@es
altLabel
Donna Ryan
@en
prefLabel
Donna H Ryan
@nl
Donna H Ryan
@sl
Donna H. Ryan
@en
Donna H. Ryan
@es
P106
P1153
7402274189
P21
P31
P496
0000-0001-8374-2277